ArticleVirulence2026
Porcine deltacoronavirus nucleocapsid protein inhibits RIG-I signaling pathway by suppressing G3BP1-mediated stress granules formation.
Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine deltacoronavirus (PDCoV) is an emerging zoonotic pathogen causing severe diarrhea in suckling piglets. Stress granules (SGs), stress-induced cytoplasmic condensates, are pivotal to the antiviral innate immune response. However, the interaction between PDCoV and SGs remains unclear. Here, we found that PDCoV triggered the formation of SGs during early infection, but these structures gradually disassembled in the late stage, while exogenously induced SGs significantly inhibited PDCoV replication. Mechanistically, we identified the nucleocapsid (N) protein as a potent SGs antagonist. The N protein can interact with Ras-GTPase-activating protein SH3-domain-binding protein 1 (G3BP1, the core component of SGs), thereby disrupting SGs assembly. Furthermore, we found that G3BP1 promotes type I interferon (IFN-I) production by recruiting retinoic acid-inducible gene-I (RIG-I). The PDCoV N protein competitively blocks this G3BP1-RIG-I interaction, leading to impaired IFN-I signaling. In addition, we found that this SGs-inhibitory function is conserved across diverse coronaviruses and correlates with structural conservation of N proteins. Our findings reveal a novel and conserved immune evasion mechanism in which coronaviruses antagonize the SGs-mediated antiviral pathway via their N proteins to promote replication. Importantly, this mechanism is structurally conserved across diverse coronaviruses, thereby identifying the N protein as a promising target for broad-spectrum antiviral development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.